For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

With finite natural resources and a growing demand for food, the world must find ways to overcome this challenge. One ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Shares of the biotech Kymera Therapeutics are up 50% since Monday, when data from an early trial hinted that its pill might ...

The company hopes to submit its lead drug later this year for FDA approval. What these 3 Bay Area biotech companies did to ...

Mizuho's Jared Holz joins the 'Fast Money' team to discuss the potential impact of expiring patents within the biotech and ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

With our incredible universities, educated workforce and geographic location, I firmly believe Connecticut can be the next ...

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.